List view / Grid view

Pascal Soriot

AstraZeneca cancels £450m Liverpool vaccine facility expansion

Under growing global competition, this development highlights potential challenges for…

10 February 2025 | By European Pharmaceutical Review

Under growing global competition, this development highlights potential challenges for the UK to uphold large-scale pharmaceutical investments.

news

AstraZeneca Canadian investment to drive R&D growth

The US$570m investment will contribute to advancing AstraZeneca’s global clinical…

24 January 2025 | By Catherine Eckford (European Pharmaceutical Review)

The US$570m investment will contribute to advancing AstraZeneca’s global clinical pipeline, a key goal of its strategy to 2030.

news

New $3.5b AstraZeneca investment to accelerate US R&D and manufacturing

This investment supports AstraZeneca’s strategy to drive the biopharma company's…

12 November 2024 | By Catherine Eckford (European Pharmaceutical Review)

This investment supports AstraZeneca’s strategy to drive the biopharma company's development in the US.

news

AstraZeneca announces $1.5b ADC manufacturing facility

The new manufacturing facility for antibody drug conjugates (ADCs) will…

20 May 2024 | By Catherine Eckford (European Pharmaceutical Review)

The new manufacturing facility for antibody drug conjugates (ADCs) will be designed to have zero carbon emissions when operational, AstraZeneca stated.

news

Pharma unites to secure renewable energy in key manufacturing markets

The new industry collaboration aims to help decarbonise the global…

29 November 2023 | By Catherine Eckford (European Pharmaceutical Review)

The new industry collaboration aims to help decarbonise the global supply chain by focusing on the energy-intensive pharmaceutical manufacturing that takes place in China and India.

news

Biopharma sees strong Q2 2023 market cap growth

Johnson & Johnson have been shifted from the top position…

21 August 2023 | By Catherine Eckford (European Pharmaceutical Review)

Johnson & Johnson have been shifted from the top position in the market capitalisation ranking for the first time, due to Eli Lilly having the largest growth during Q2 2023, research shows.

news

AstraZeneca appoints new EVP of BioPharmaceuticals R&D

Former Senior Vice President, Head of Research and Product Development…

28 July 2023 | By Catherine Eckford (European Pharmaceutical Review)

Former Senior Vice President, Head of Research and Product Development of Alexion, will succeed Mene Pangalos as Executive Vice President, BioPharmaceuticals R&D at AstraZeneca.

close up of person's hand sliding a wooden puzzle block with people icons on it into a space in a larger puzzle - idea of appointments or recruitment

article

Pharmaceutical C-suite update

With two knighthoods in the last month, here EPR discusses…

21 June 2022 | By Hannah Balfour (European Pharmaceutical Review)

With two knighthoods in the last month, here EPR discusses five developments in the drug development community’s C-suite.

news

AstraZeneca announces new site plans at innovation hub

AstraZeneca has announced plans to invest in a new facility,…

4 May 2022 | By Mandy Parrett (European Pharmaceutical Review)

AstraZeneca has announced plans to invest in a new facility, uniting its R&D activities with commercial and corporate functions in Boston, US.

news

AstraZeneca reveals $15.54 billion in revenues in H1 2021

H1 financial results show AstraZeneca’s revenues grew by 23 percent…

3 August 2021 | By Hannah Balfour (European Pharmaceutical Review)

H1 financial results show AstraZeneca’s revenues grew by 23 percent in 2021, with $14.37 billion attributed to activities aside from COVID-19 vaccine sales.

news

AstraZeneca to provide EU with extra nine million doses of COVID-19 vaccine following dispute

After manufacturing delays, AstraZeneca will now provide the EU with…

1 February 2021 | By Victoria Rees (European Pharmaceutical Review)

After manufacturing delays, AstraZeneca will now provide the EU with the 40 million COVID-19 vaccine doses it originally agreed to supply.

gloved hand holding a vial labelled 'COVID-19 vaccine'

news

AZD1222 vaccine for COVID-19 is safe and effective in Phase III trials

Interim analysis shows AZD1222 vaccine is effective at preventing COVID-19,…

9 December 2020 | By Hannah Balfour (European Pharmaceutical Review)

Interim analysis shows AZD1222 vaccine is effective at preventing COVID-19, with no severe cases or hospitalisations reported more than 21 days after first injection.

news

Clinical trials to study AstraZeneca’s COVID-19 vaccine resume globally

Clinical trials for AZD1222, the AstraZeneca COVID-19 vaccine candidate, have…

28 October 2020 | By Victoria Rees (European Pharmaceutical Review)

Clinical trials for AZD1222, the AstraZeneca COVID-19 vaccine candidate, have resumed across the world after confirmation it is safe to do so.

news

Clinical trial for AstraZeneca Oxford COVID-19 vaccine candidate to resume

After the clinical trial for AZD1222 was halted last week,…

14 September 2020 | By Victoria Rees (European Pharmaceutical Review)

After the clinical trial for AZD1222 was halted last week, the studies for AstraZeneca's COVID-19 vaccine candidate will now resume.

news

AstraZeneca to supply Europe with up to 400 million doses of COVID-19 vaccine

An agreement between AstraZeneca and the European Commission means the…

17 August 2020 | By Victoria Rees (European Pharmaceutical Review)

An agreement between AstraZeneca and the European Commission means the company will supply up to 400 million doses of its AZD1222 COVID-19 vaccine.

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Recommended

Pascal Soriot